Pomalidomide(pomalyst) 4MG cap

Ended Awarded Last action

Contract number
36C24526N0592
Awardee
Awarding agency
Obligated
$16,422

Award facts

Contract value 100% obligated
$16,421.95 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Memphis, TN 38141, USA

Award details come from SAM.gov/FPDS.

About this award

Veterans Integrated Service Network 5 issued a BPA call to Bristol-Myers Squibb Company on May 21, 2026, for Pomalidomide (Pomalyst) 4mg capsules, with a ceiling value of $16,421.95 and an ultimate completion date of May 26, 2026. The call is placed under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract. Performance occurs in Memphis, Tennessee. The order is firm fixed price with no set-aside designation.

Quick answers

Who was awarded contract 36C24526N0592?

36C24526N0592 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 5 (Veterans Health Administration) on May 21, 2026.

How much is contract 36C24526N0592 worth?

The government has obligated $16,422 on 36C24526N0592.

Is contract 36C24526N0592 an order under another contract?

Yes. 36C24526N0592 is a BPA call under 36F79724D0101-36E79726A0010, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24526N0592 competed?

The extent of competition for 36C24526N0592 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award